Evidence map›Paper›PMID 21863892›Full record

ArticleJournal of proteome research2011

Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.

Li Liang, Xiaolin Tan, Silvia Juarez, Homarh Villaverde, Jozelyn Pablo, Rie Nakajima-Sasaki, Eduardo Gotuzzo, Mayuko Saito, Gary Hermanson, Douglas Molina and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of proteome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 36 citations in OpenAlex.

  1. The synergistic pathogenic mechanism ofJournal of medical microbiology · 2025
    Article
  2. Developments and Applications of Functional Protein Microarrays.Molecular & cellular proteomics : MCP · 2020
    Review
  3. Protein-Specific Features Associated with Variability in Human Antibody Responses toThe American journal of tropical medicine and hygiene · 2018
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Overview of protein microarrays.Current protocols in protein science · 2013
    Review
  19. A foodborne outbreak of brucellosis at a police station cafeteria, Lima, Peru.The American journal of tropical medicine and hygiene · 2013
    Article
  20. Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Li LiangDepartment of Medicine, Division of Infectious Diseases, University of California, Irvine, California 92697, United States.
Xiaolin Tan
Silvia Juarez
Homarh Villaverde
Jozelyn Pablo
Rie Nakajima-Sasaki
Eduardo Gotuzzo
Mayuko Saito
Gary Hermanson
Douglas Molina
Scott Felgner
W John W Morrow
Xiaowu Liang
Robert H Gilman
D Huw Davies
Renée M Tsolis
Joseph M Vinetz
Philip L Felgner
University of California, Irvine · USAntigen Discovery (United States) · USUniversidad Peruana Cayetano Heredia · PEPrisma · PEUniversity of California, Davis · USUniversity of California, San Diego · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Development and Testing of Human Brucellosis Diagnostics in an Endemic CountryU01AI075420 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2007 to 2011
$5.3M
Multiplex Serodiagnostic Protein MicroarrayU01AI078213 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FELGNER, PHILIP LOUIS · 2008 to 2012
$3.7M
Seriodiagnostic arrays for biodefense and emerging infectious diseasesR44AI058365 · NIAID · IMMPORT THERAPEUTICS, INC. · PI DAVIES, DAVID HUW · 2008 to 2010
$3.0M
Translational Research Development for Endemic Infectious Diseases of AmazoniaD43TW007120 · FIC · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2004 to 2020
$3.0M
Patient-Oriented Research in Tropical Infectious DiseasesK24AI068903 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2006 to 2015
$1.5M
FIC NIH HHS D43 TW007120FIC NIH HHS D43TW007120NIAID NIH HHS 1K24AI068903NIAID NIH HHS 1U01AI075420NIAID NIH HHS 5R44AI058365-05NIAID NIH HHS K24 AI068903NIAID NIH HHS R44 AI058365NIAID NIH HHS U01 AI075420NIAID NIH HHS U01 AI078213NIAID NIH HHS U01AI078213NIAID NIH HHS U54 AI065359NIAID NIH HHS U54AI065359
6 · The paper itself

Abstract

A complete understanding of the factors that determine selection of antigens recognized by the humoral immune response following infectious agent challenge is lacking. Here we illustrate a systems biology approach to identify the antibody signature associated with Brucella melitensis (Bm) infection in humans and predict proteomic features of serodiagnostic antigens. By taking advantage of a full proteome microarray expressing previously cloned 1406 and newly cloned 1640 Bm genes, we were able to identify 122 immunodominant antigens and 33 serodiagnostic antigens. The reactive antigens were then classified according to annotated functional features (COGs), computationally predicted features (e.g., subcellular localization, physical properties), and protein expression estimated by mass spectrometry (MS). Enrichment analyses indicated that membrane association and secretion were significant enriching features of the reactive antigens, as were proteins predicted to have a signal peptide, a single transmembrane domain, and outer membrane or periplasmic location. These features accounted for 67% of the serodiagnostic antigens. An overlay of the seroreactive antigen set with proteomic data sets generated by MS identified an additional 24%, suggesting that protein expression in bacteria is an additional determinant in the induction of Brucella-specific antibodies. This analysis indicates that one-third of the proteome contains enriching features that account for 91% of the antigens recognized, and after B. melitensis infection the immune system develops significant antibody titers against 10% of the proteins with these enriching features. This systems biology approach provides an empirical basis for understanding the breadth and specificity of the immune response to B. melitensis and a new framework for comparing the humoral responses against other microorganisms.

Indexed as

Gene Expression RegulationAntibodiesBacterial ProteinsBrucella melitensisBrucellosisCell MembraneHumansImmune SystemLipopolysaccharidesMass SpectrometryOpen Reading FramesProtein Array AnalysisProteomicsReproducibility of ResultsSystems BiologyAntibodiesBacterial ProteinsLipopolysaccharides

Identifiers

PMID21863892
PMCPMC3189706
OpenAlexW1993887481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.